Angio Suites Market size is estimated to reach ~USD 849 Billion by the end of 2035 by growing at a CAGR of ~9% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of angio suites was ~USD 367 Billion. The growth of the market can be attributed to the increasing prevalence of cardiovascular and other chronic diseases. WHO reports that cardiovascular diseases (CVDs) account for the majority of deaths worldwide, with 17.9 million people estimated to have died from CVDs in 2019. The prevalence of chronic diseases in the United States is approximately 133 million, representing more than 40% of the total population. Approximately 157 million people were expected to have multiple conditions in 2020, with 81 million being diagnosed with multiple conditions. Angio suites are equipped with advanced imaging technologies, such as CT scanners and MRI machines, that are widely used to cardiovascular diagnostics and treatment.
In addition to these, factors that are believed to fuel the growth of angio suites market include increased funding, grants, and investments by public-private organizations in healthcare along with growing demand for minimally invasive surgeries (MIS). A total of 10.6 million MIS encounters were recorded in 2016, 10.6 million in 2017, and 10.7 million in 2018, respectively. Furthermore, the percentage of encounters involving MIS procedures in 2016, 2017, and 2018 was 16.9%, 17.4%, and 18%. Angio suites are equipped with imaging devices that allow surgeons to perform complex procedures with precision, thus reducing the risk of complications and allowing patients to recover more quickly. Additionally, they are cost-effective and can be used for a variety of procedures, making them an attractive option for hospitals. They are also used to perform minimally invasive surgeries, such as angioplasty and stenting, to improve blood flow in the affected areas.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
~9% |
Base Year Market Size (2022) |
~ USD 367 Billion |
Forecast Year Market Size (2035) |
~ USD 849 Billion |
Regional Scope |
|
Growth Drivers
Challenges
The global angio suites market is segmented and analyzed for demand and supply by application into angioplasty, therapeutic stenting, obstruction bypass, intravascular therapy and others. Out of these, the angioplasty segment is estimated to gain the largest market share of about ~42% in the year 2035. The growth of the segment can be attributed to the rising incidence of cardiovascular diseases, increased use of percutaneous coronary intervention (PCI) procedure, and technological advancements in angioplasty and stenting systems. In addition, the increasing awareness of angioplasty and its advantages over open surgeries is further driving segment growth. In addition, increasing angioplasty success rates are expected to fuel segment growth. For instance, approximately 88% of the patients who undergo coronary angioplasty are successful in opening the coronary arteries.
The global angio suites market is segmented and analyzed for demand and supply by type into a biplane and single plane. Out of these, the biplane angio suites segment is estimated to gain a significant market share of about ~65% in the year 2035. The growth of the segment can be attributed to its better imaging capabilities while performing angiography procedures. The biplane angio suites are highly preferred by medical professionals owing to their ability to provide superior imaging capabilities, as well as their cost-effectiveness and space-saving design. Additionally, they can be used for a variety of imaging techniques such as 3D imaging, fluoroscopy, and interventional radiology. These features have contributed to an increased demand for biplane angio suites, resulting in a significant market share of the segment.
Our in-depth analysis of the global angio suites market includes the following segments:
By Type |
|
By Application |
|
By Equipment |
|
By End User |
|
The market share of angio suites in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of heart diseases such as stroke and heart attack along with the growing awareness of the importance of early diagnosis and treatment of such diseases. In accordance with the Centers for Disease Control and Prevention, a heart attack occurs every 40 seconds in the United States, and about 805,000 people suffer a heart attack every year. A heart stroke affects more than 795,000 people in the country every year, including 610,000 first strokes. Angio suites are specialized rooms equipped with advanced imaging technology and other medical equipment that is used to diagnose and treat heart diseases. This allows doctors to quickly diagnose and start treating heart problems, thereby reducing the risk of complications. Additionally, there are a number of initiatives that are being implemented to promote the development of new technologies in the healthcare sector, such as artificial intelligence and machine learning. These technologies are expected to revolutionize patient care and health outcomes, resulting in increased demand for medical services in the region.
The Asia Pacific angio suites market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the increasing obesity prevalence and sedentary lifestyle among region's population. As obesity prevalence increases, the risk of developing chronic illnesses such as diabetes and heart disease also increases. This contributes to an increase in demand for angio suites, which are medical devices used to diagnose and treat these conditions. Similarly, as people become more sedentary, they are more prone to develop health problems, giving rise to an increased demand for angio suites services. Moreover, a growing availability of cutting-edge angio suites technology, including advanced imaging systems and robotic-assisted systems, as well as government investments in healthcare infrastructure, including hospitals and clinics, is expected to contribute to regional market growth.
Further, the angio suites market in the Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the availability of skilled healthcare professionals as well as technological advances. As healthcare professionals become more skilled, they are able to provide more efficient and accurate diagnosis and treatments. Also, technological advances such as the development of angio suites, which are used to diagnose and treat illnesses, have made it possible to provide better care. Furthermore, the presence of well-established healthcare infrastructure and the growing number of hospitals and specialty clinics are also contributing to the growth of the market in Europe.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing number of cardiovascular and neurological disorders, growing prevalence of lifestyle-related diseases, and technological advancements in angio suites are the major factors driving the market growth.
Ans: The market size of angio suites is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023 – 2035.
Ans: Long approval process for new products and the lack of reimbursement policies in many countries are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Onex Corporation, Canon Medical Systems Corporation, Carestream Health, Hitachi, Ltd., Koninklijke Philips N.V., 3D Systems Inc., ZEISS International, Hologic, Inc. and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, application, equipment, end user, and by region.
Ans: The biplane segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)